Daniel Wallerstorfer is an experienced leader in the biotechnology sector, currently serving as Chief Scientific Officer at 10X Health System and holding the CEO position at Darwin AG since November 2021. Previously, Daniel held the role of Chief Scientific Officer at REVIV Global and has been the CEO of Novogenia GmbH since its inception in 2009, after founding the company that developed a high-tech medical genetic laboratory. Additionally, Daniel is the CEO of Innovogene. Daniel's academic background includes a Bachelor of Science in Molecular Biology and a Doctor of Philosophy in Biotechnology, both obtained from the University of Manchester between 2003 and 2009.
This person is not in any offices